Di Cesare, A.; Rosi, E.; Trovato, E.; Pescitelli, L.; Panduri, S.; Manzo Margiotta, F.; Michelucci, A.; Capalbo, E.; Dragotto, M.; Magnano, M. .; Rossari, S.; Savarese, I.; Buggiani, G.; Milanesi, N.; Lorenzoni, E.; Ricceri, F.; Romanelli, M.; Rubegni, P.; Pimpinelli, N.; Prignano, F. Therapeutic Modulation Of Peripheral Blood Cells And Inflammatory Indices During 52 Weeks Of Risankizumab In Responder Patients With Moderate-to-Severe Psoriasis: Results From A Multicenter Prospective Study. Dermatol Pract Concept 2025, 15 (4), 5733. https://doi.org/10.5826/dpc.1504a5733.